MET and cancer: However, several studies reported that deregulation or improper activation of the HGF/Met signaling pathway can promote cytoskeletal changes, leading to the acceleration of proliferation, angiogenesis, motility, and survival and invasive/metastatic abilities of many cancer cells [81].